Earth Science Tech, Inc. (ETST) Finishes Audit for
Post# of 333
(Total Views: 263)
Posted On: 05/18/2018 8:41:05 PM
Earth Science Tech, Inc. (ETST) Finishes Audit for Previous Years, Submits Form 10 to Become Fully Reporting
- ETST now begins 2017 fiscal year audit, which is required along with the approved Form 10 to uplist to the OTCQB
- Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing high-grade hemp cannabidiol (CBD)
- In a news release, Dr. Michel Aube, CEO and chief science officer of ETST, says that, following completion of audit, he sees investor confidence growing and ETST seeking to secure its first big round of financing
Earth Science Tech, Inc. (OTC: ETST) has announced completion of its audit for FY2015 and FY2016 and submitted its Form 10 to become fully reporting (http://nnw.fm/Pg1Ub). ETST is now commencing its audit for FY2017. That audit and the approved Form 10 submission are required for an uplisting to the OTCQB Venture Market.
In a news release, Dr. Aube said, “We are in touch with institutional and private investors that were waiting for ETST to become a fully reporting company before investing the necessary amount to commercialize our projects. We can now resume our discussions with them.” He also said that transparency is a key tool in the growth of ETST’s business and gaining investor confidence.
Florida-based ETST is an innovative biotech company marketing a repositioned line of High Grade Full Spectrum cannabidiol. Focused on manufacturing, marketing and distributing its cannabinoid products to the pharmaceutical and nutraceutical markets, it also conducts R&D on low cost, non-invasive medical devices.
Nickolas Tabraue, ETST director and president, added, “This is a major achievement for ETST, and becoming a fully reporting OTCQB company is going to open many opportunities while boosting investor confidence.”
ETST holds four wholly owned subsidiaries. One is Earth Science Pharmaceutical, which develops medical diagnostic tools and vaccines. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD is focused on manufacturing and distributing in the recreational space. Earth Science Foundation, Inc. is in the process of becoming a non-profit, and it will accept grants and donations to conduct further studies.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- ETST now begins 2017 fiscal year audit, which is required along with the approved Form 10 to uplist to the OTCQB
- Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing high-grade hemp cannabidiol (CBD)
- In a news release, Dr. Michel Aube, CEO and chief science officer of ETST, says that, following completion of audit, he sees investor confidence growing and ETST seeking to secure its first big round of financing
Earth Science Tech, Inc. (OTC: ETST) has announced completion of its audit for FY2015 and FY2016 and submitted its Form 10 to become fully reporting (http://nnw.fm/Pg1Ub). ETST is now commencing its audit for FY2017. That audit and the approved Form 10 submission are required for an uplisting to the OTCQB Venture Market.
In a news release, Dr. Aube said, “We are in touch with institutional and private investors that were waiting for ETST to become a fully reporting company before investing the necessary amount to commercialize our projects. We can now resume our discussions with them.” He also said that transparency is a key tool in the growth of ETST’s business and gaining investor confidence.
Florida-based ETST is an innovative biotech company marketing a repositioned line of High Grade Full Spectrum cannabidiol. Focused on manufacturing, marketing and distributing its cannabinoid products to the pharmaceutical and nutraceutical markets, it also conducts R&D on low cost, non-invasive medical devices.
Nickolas Tabraue, ETST director and president, added, “This is a major achievement for ETST, and becoming a fully reporting OTCQB company is going to open many opportunities while boosting investor confidence.”
ETST holds four wholly owned subsidiaries. One is Earth Science Pharmaceutical, which develops medical diagnostic tools and vaccines. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD is focused on manufacturing and distributing in the recreational space. Earth Science Foundation, Inc. is in the process of becoming a non-profit, and it will accept grants and donations to conduct further studies.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)